IMR Press / FBL / Special Issues / 1437296963317321730

Cancer Stem Cell Therapy

Submission deadline: 31 May 2022
Special Issue Editors
Pyung-Hwan Kim
Department of Biomedical Laboratory Science, College of Medical Science, Konyang University, 35365 Daejon, Republic of Korea
Interests: Cancer Gene Therapy; Cancer Stem Cells; Biomarkers; Nano-stem Cell Complex Engineering
Special Issue Information

Dear Colleagues,

Despite the development of innovative medical technologies, cancer remains a worldwide health concern. Cancer commonly recurs despite various treatments ranging from first-generation chemotherapy to third-generation immune checkpoint inhibitors. Tumor recurrence has been linked to cancer stem cells, thus, both cancer cells and cancer stem cells must be treated for effective treatment strategies. However, cancer stem cells are a minor subpopulation within the total tumor cell population, and current biomarkers that identify cancer stem cells have limitations in clinical application due to marker heterogeneity and plasticity within the population. Therefore, a targeting strategy is needed along with the discovery of new biomarkers to treat cancer stem cells, and improve diagnoses and prognoses. This special issue addresses a wide range of topics linked to advances in cancer stem cell biology such as the discovery of new cancer stem cell biomarkers and clinical applications of these biomarkers. Recent research and new advancements in this field, as well as other related topics, are welcome.

Prof. Pyung-Hwan Kim

Guest Editor

Keywords
Cancer Gene Therapy
Cancer Stem Cells
Biomarkers
Nano-stem Cell Complex Engineering
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Back to top